Skip to main content
. 2023 Jun 20;6(2):390–415. doi: 10.20517/cdr.2023.16

Table 1.

Characteristics based on partial nano drug delivery systems

Classification Nanocarriers Nanocarriers properties Disadvantage
Organic nanocarriers Liposomes (a) Amphiphilic, biocompatible(b) Wide adaptability(c) Targeting potential(d) Ease of modification (a) Poor stability, easy to be affected by metal radiation, high temperature, pH, and enzymes(b) Low drug loading rate
Polymeric micelles (a) Long retention time in the body(b) Suitable carrier for water-insoluble drug(c) Ease of functional modification(d) Biocompatible, self-assembling, biodegradable(e) Special “core-shell” structure, targeting potential Poor physical stability, resulting in drug leakage and sudden release
Polymeric nanoparticles (a) Water-soluble, nontoxic, and biodegradability(b) High drug loading(c) Selective accumulation and retention in tumor tissue (EPR effect)(d) Active targeting and smart response (a) Easy binding to negatively charged non-specific cells or proteins(b) Low gene transfection efficiency
DNA/RNA (a) Easy synthesis and modification(b) Low immunogenicity(c) Excellent specificity and affinity(d) Active targeting and Intelligent drug release (a) Poor cellular uptake(b) Poor stability
HSA (a) Safety, no immunogenicity, good biocompatibility(b) Biodegradable(c) Passive targeting (a) Large particle size and easy degradation(b) Preparation method is easy to cause increased toxicity(c) Limited sources of HSA
Inorganic nanocarriers Metal nanoparticles (a) Biocompatible(b) Easy preparation (a) Need surface modification(b) Poor biocompatibility
Non-metallic nanoparticles (a) Low surface potential(b) Low drug loading(c) Easy aggregation

EPR: Enhanced permeability and retention; HSA: human serum albumin.